<DOC>
	<DOCNO>NCT00784875</DOCNO>
	<brief_summary>The purpose study compare investigational drug ( LY2624803 ) placebo zolpidem treatment outpatient chronic insomnia .</brief_summary>
	<brief_title>An Efficacy Study Compound LY2624803 Treatment Patients With Chronic Insomnia</brief_title>
	<detailed_description>Outpatients chronic insomnia participate study treat four 2-week treatment period bedtime dose either placebo , zolpidem , LY2624803 1 mg , LY2624803 3 mg . Neither patient investigator tell treatment give treatment period . A patient complete four treatment period treat placebo 1 , 2 , 3 period ; zolpidem 0 , 1 , 2 period ; LY2624803 either 1 2 period . No patient receive placebo four 2-week treatment period . All patient receive LY2624803 least one four 2-week treatment period . During treatment period , patient record information morning sleep night , even function since wake . Patients also wear wrist actigraphy device record physical activity . At conclusion treatment period , patient answer question sleep , function , health , relative preference treatment .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Patients must 18 85 year age , stable living situation Clinical diagnosis either primary insomnia `` secondary '' insomnia ( comorbid depression , anxiety , and/or medical illness ) Insomnia system must least moderate severity within month prior study entry , must include difficulty stay asleep and/or problem awaken earlier desire Psychiatric medical condition present must stable 3 month prior study entry , expect worsen significantly require hospitalization participation study Ongoing treatment psychiatric medical condition present must stable 3 month prior study entry , must expect remain stable participation study Patients must willing abstain take medication ( study drug ) help sleep participation study Patients must willing consistently spend least 7 hour night either sleep try sleep participation study Patients must able speak read English capable use computer web browser ( computer internet connection provide patient need ) Unusual unstable sleep/wake schedule , rotate shift work Severe unstable psychiatric medical illness Suicidal ideation Substance abuse Known obstructive sleep apnea , restless leg syndrome , periodic limb movement disorder History seizures Body Mass Index &gt; 33 Clinically significant abnormality clinical chemistry , hematology , urinalysis , and/or electrocardiogram Anticipated inability regularly use medication might reduce motor cognitive functioning sleeping hour , person might often need `` call '' , drive car , responsible care another person sleep hour Contraindication zolpidem History breast cancer An estimate glomerular filtration rate ( GFR ; index renal function ) &lt; 30 mL/min study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>